Valneva Se Stock Today
| INRLF Stock | USD 2.89 0.21 6.77% |
PerformanceWeak
| Odds Of DistressLow
|
Valneva SE is trading at 2.89 as of the 19th of July 2025. This is a 6.77 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.89. Valneva SE has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 20th of April 2025 and ending today, the 19th of July 2025. Click here to learn more.
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. The company was founded in 1998 and is headquartered in Saint-Herblain, France. Valneva Se is traded on OTC Exchange in the United States.. The company has 138.22 M outstanding shares. More on Valneva SE
Moving against Valneva Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Valneva Pink Sheet Highlights
| Chairman | Thomas Lingelbach |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Valneva SE [INRLF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Small-Cap' category with a current market capitalization of 944.39 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Valneva SE's market, we take the total number of its shares issued and multiply it by Valneva SE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Valneva SE classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 138.22 M outstanding shares.
Valneva SE has accumulated about 336.22 M in cash with 76.9 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.87.
Check Valneva SE Probability Of Bankruptcy
Ownership AllocationValneva SE shows a total of 138.22 Million outstanding shares. Valneva SE has 17.56 % of its outstanding shares held by insiders and 21.62 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Valneva Ownership Details
Valneva SE Risk Profiles
| Mean Deviation | 0.4833 | |||
| Standard Deviation | 2.27 | |||
| Variance | 5.14 | |||
| Risk Adjusted Performance | 0.0092 |
Valneva Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Valneva SE without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Valneva SE Corporate Management
| Dipal Patel | Chief Board | Profile | |
| Laetitia BachelotFontaine | Investor Relations Manager | Profile | |
| JuanCarlos MD | Chief Board | Profile | |
| Gerald Strohmaier | VP Resource | Profile | |
| Peter Buhler | CFO Member | Profile |
Other Information on Investing in Valneva Pink Sheet
Valneva SE financial ratios help investors to determine whether Valneva Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valneva with respect to the benefits of owning Valneva SE security.